Tier 3 — preclinical

Fisetin Regulates Nrf2 Expression and the Inflammation-Related Signaling Pathway to Prevent UVB-Induced Skin Damage in Hairless Mice

Po-Yuan Wu, Jia-Ling Lyu, Yi-Jung Liu, Ting-Yi Chien, Hao-Cheng Hsu, Kuo-Ching Wen, Hsiu-Mei Chiang
International Journal of Molecular Sciences 2017 Vol. 18, No. 10, page 2118

Bibliography

PubMed
PMID 28994699
PubMed Central
PMC5666800
Funding
This study was funded by China Medical University (CMU102-ASIA-18, CMU103-ASIA-11), Taichung, and the Ministry of Science and Technology (MOST 104-2320-B-039-006), Taipei, Taiwan.
Competing interests
The authors declare no conflict of interest.

Study snapshot

DesignPreclinical in vivo animal study
ModelFemale BALB/c hairless mice
Sample25 mice (5 groups of 5 mice)
InterventionTopical application of fisetin (50 µM or 200 µM) following UVB irradiation
Duration10 weeks
EndpointsSkin barrier function (transepidermal water loss) ; Skin erythema (a* value) ; Wrinkle formation ; Epidermal thickness ; Collagen content ; Expression levels of MMP-1, MMP-2, COX-2, IL-6, NF-κB, Nrf2, aquaporin, and filaggrin

What the study showed, in plain terms

Chronic exposure to ultraviolet (UVB) radiation damages the skin barrier, triggers oxidative stress, and drives the degradation of collagen, ultimately resulting in premature aging and wrinkle formation. Because UVB exposure deeply impacts skin structure through inflammation, targeted antioxidants are frequently explored as preventative treatments.

In this study, researchers investigated whether applying fisetin topically could protect the skin of hairless mice from UVB-induced damage over a 10-week period. They measured physical markers of skin aging like wrinkle formation and water loss, alongside cellular markers of inflammation and tissue degradation.

The findings demonstrated that topically applied fisetin significantly preserved skin barrier function and prevented UVB-induced epidermal thickening and collagen loss. Fisetin achieved this by blocking the inflammatory signals that break down the extracellular matrix and simultaneously boosting the body's natural antioxidant defense mechanisms.

Key findings

  • Skin Barrier Preservation: Topical fisetin mitigated UVB-induced transepidermal water loss and maintained the expression of essential hydration proteins like aquaporin and filaggrin.
  • Reduced Tissue Degradation: Fisetin significantly prevented the UVB-induced overproduction of collagen-destroying enzymes (MMP-1 and MMP-2), leading to visibly reduced wrinkle formation.
  • Anti-Inflammatory Action: The treatment suppressed key markers of photoinflammation, reducing the expression of COX-2, IL-6, and NF-κB in the dorsal skin.
  • Enhanced Antioxidant Defense: Fisetin successfully upregulated Nrf2 expression, counteracting the oxidative stress generated by chronic UVB exposure.

What this study can and cannot tell us

  • Preclinical Model: The results were observed in a hairless mouse model and require clinical trials in humans to confirm the cosmetic and photoprotective efficacy of topical fisetin formulations.
  • Administration Route: The study only evaluated topical application, leaving it unclear if oral fisetin supplementation provides similar photoprotective benefits to the skin.
Reviewed by , Medical Advisory Board · Last verified against PubMed on 23 July 2026